Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,752.18
+0.30%
DAX
26,237.10
-0.39%
CAC 40
8,542.80
-0.43%
STOXX 50
6,500.51
-0.46%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 09 December 2025 9:05 am  |  Updated:  Wednesday 10 December 2025 9:33 am

Vitabiotics: Profit cut ahead of of potential £1bn sale

By: Jon Robinson

Add as a preferred source on Google
Tej Lalvani smiling during a business conference, wearing a suit and tie, highlighting his role as a prominent entrepreneur
Former Dragons' Den star Tej Lalvani is the CEO of Vitabiotics.

Profit at Vitabiotics, the pharmaceutical giant owned by former Dragons’ Den star Tej Lalvani, has been cut ahead of a potential £1bn sale.

Reports emerged towards the start of 2025 that the London-headquartered business had revived plans to sell itself in a move which valued it at £1bn.

At the start of December it was also reported that Indian pharmaceutical giant Lupin Pharma was in early-stage discussions to acquire Vitabiotics alongside EQT Partners and TPG Capital.

Vitamins giant Vitabiotics is run by former Dragons’ Den star Tej Lalvani and was founded by his father, Kartar Lalvani, in 1971.

Tej Lalvani appeared on Dragons’ Den from 2017 to 2021.

Now, new accounts filed with Companies House have revealed that Vitabiotics’ pre-tax profit was cut from £55.2m to £28.4m in 2024.

The results, which have been filed late, also show its turnover dipped from £196.4m to £195.6m over the same period.

Read more

Sweeping job cuts at GSK to fund £400m Cambridge campus

Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.

Unlike the prior year, Vitabiotics did not issue a dividend – having paid out £15m in its previous 12 months.

Inflation eats into Vitabiotics’ bottom line

A statement signed off by the board said: “The company’s overall net saes figure of £195.6m reflects positive continued growth across all sales channels, with the exception of a modest reduction in export sales in 2024, due to specific local market conditions.”

It added: “Inflationary increases in cost of goods and transportation costs flowed through to operating profit for the year.

“In addition, there was an increase in administrative expenses and a £15m revaluation adjustment related to investment properties.”

Vitabiotics also said that there was also a £5m bad debt provision created for amounts owed by Vitabiotics Turkey.

On its future, Tej Lalvani’s company said: “The focus on developing our brands internationally will continue with initiatives such as a regional marketing hub based in Egypt to serve the MENA region and strengthening of the supply chain and export functions to provide even better service to our international partners.”

Read more

Government urged to refuse £1bn British Steel repayment to Chinese former owner 

Labour's Jonathan Reynolds unveiled the industrial strategy in June.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Retail

People & Organisations

  • Companies House
  • Dragons' Den
  • pharmaceuticals
  • Tej Lalvani
  • Vitabiotics
  • Vitamins

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Monzo chair makes early exit after boardroom rift

  • Aldi boss wades into supermarket ‘price-gouging’ row

  • New Premier League rules could see £11bn invested into new stadiums

More from Morning Wire

  • Sweeping job cuts at GSK to fund £400m Cambridge campus

    Pharma
    Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.
  • Government urged to refuse £1bn British Steel repayment to Chinese former owner 

    Politics
    Labour's Jonathan Reynolds unveiled the industrial strategy in June.
  • Terry Smith dubs weight-loss giant Novo Nordisk ‘investment disaster’

    Investing
    Terry Smith, founder of Fundsmith, speaking at a business conference, wearing a suit and tie, with a focused expression.
  • As it happened: Stocks jump as oil drops; Unilever shares soar on decade-best sales

    Markets
    Unilever owns brands ranging from Ben and Jerry's to Dove
  • Iwoca closes bumper debt facility as sale speculation mounts

    Fintech
    Christoph Rieche (right) and James Dear (left) co-founded Iwoca in 2011.
  • North Sea is not competitive, says BP boss days after exit

    Markets
    British Petroleum BP forecourt with fuel pumps and company signage visible in a business setting, highlighting energy serv...
  • HSBC kicks off $1bn share buyback after profit smashes forecast

    Banking
    HSBC's stock has taken a hit due to the huge tariffs slapped on Asian countries.
  • L&G cheers push into private credit as profit jumps

    Markets
    Legal & General is reported to be eying Natwest's pension provider.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook